Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership856 shares
Latest Disclosed Value $ 448,091
Pnc Financial Services Group, Inc. reports 209.03% increase in ownership of YDO1 / Madrigal Pharmaceuticals, Inc.

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 856 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $385,457 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 277 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 209.03% during the quarter. The current value of the position is $364,827 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 856 579 209.03 448 178.26 0.0003
2026-02-06 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 277 15 5.73 161 34.17 0.0001
2025-11-07 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 262 19 7.82 120 64.38 0.0001
2025-08-08 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 243 -130 -34.85 74 -40.65 0.0000
2025-05-09 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 373 -1 -0.27 124 6.96 0.0001
2025-02-07 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 374 4 1.08 115 47.44 0.0001
2024-11-08 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 370 -5 -1.33 79 -25.71 0.0001
2024-08-09 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 375 39 11.61 105 17.98 0.0001
2024-05-10 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 336 241 253.68 90 323.81 0.0001
2024-03-22 2023-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 95 20 26.67 22 110.00 0.0000
2024-02-09 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 95 20 22 0.0000
2023-11-13 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 75 21 38.89 11 -16.67 0.0000
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 54 40 285.71 12 300.00 0.0000
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 3 -25.00 0.0000
2023-02-10 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 4 0.0000
2022-11-10 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 0 -100.00
2022-08-12 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 2 0.00 0.0000
2022-05-12 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 -6 -30.00 2 -33.33 0.0000
2022-02-11 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 20 1 5.26 3 50.00 0.0000
2021-11-05 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 19 -1 -5.00 2 0.00 0.0000
2021-08-06 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 20 -2 -9.09 2 0.00 0.0000
2021-05-07 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 22 2 10.00 2 0.00 0.0000
2021-02-12 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 20 0 0.00 2 0.00 0.0000
2020-11-06 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 20 0 0.00 2 0.00 0.0000
2020-08-28 2020-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 20 6 42.86 2 0.0000
2020-08-07 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 20 6 2 0.4153
2020-05-08 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 0 -100.00
2020-02-07 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 2 0.00 0.0000
2019-11-08 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 2 0.00 0.0000
2019-08-09 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 2 0.00 0.0000
2019-05-10 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 0 0.00 2 0.00 0.0000
2019-02-08 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 14 -1,357 -98.98 2 -99.32 0.0000
2018-11-09 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,371 -15 -1.08 293 -24.29 0.0003
2018-08-10 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,386 -519 -27.24 387 73.54 0.0004
2018-05-11 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,905 1,905 223 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.